Medicared For All Logo

Muhammad Janjua in Tulsa, Oklahoma

Home Oklahoma Tulsa

Muhammad Janjua has Hematology/oncology as his primary medical specialty. Their primary office is: 6600 S Yale Ave in Tulsa, Oklahoma. There is an additional office location, for a total of two, for Muhammad Janjua that can be viewed further down.

They're a part of the: Warren Clinic Inc medical group which has around 605 members. You can call their office at 918-488-6000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2002 (around 22 years of experience). They are listed as doing telehealth appointments.


Muhammad Janjua Office Phone and Directions

Muhammad Janjua
Warren Clinic Inc
6600 S Yale Ave
Tulsa, Oklahoma 74136
918-488-6000


Patient Ratings
Please rate your experience with Muhammad Janjua below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 918-488-6000


Enter a starting address:


Healthcare Info for Muhammad Janjua

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2002
The Primary Medical Specialty for Muhammad Janjua is listed as: Hematology/oncology
Approximate Years of Experience: 22
PAC (PECOS ID)#: 8426180035
NPI #: 1124159678
NPI Created On: 03/08/2007
NPI Last Updated Listed as: 10/08/2018
Primary Taxonomy Code: 207R00000X
License Number:
28659
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Blue Cross Blue Shield
  • CommunityCare HMO Inc.
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, ENGLISH.


Services and Procedures include:

  1. New patient office or other outpatient visit, typically 45 minutes
  2. Established patient office or other outpatient visit, typically 15 minutes
  3. Established patient office or other outpatient, visit typically 25 minutes
  4. Established patient office or other outpatient, visit typically 40 minutes
  5. Initial hospital inpatient care, typically 50 minutes per day
  6. Initial hospital inpatient care, typically 70 minutes per day
  7. Subsequent hospital inpatient care, typically 25 minutes per day
  8. Subsequent hospital inpatient care, typically 35 minutes per day
  9. Hospital discharge day management, 30 minutes or less
  10. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $13

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783729977

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01


Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783729979

Being Disputed:: No

Product Related: Yes


Payments Total: $13

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783651589

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 834960803

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HORMONE THERAPY

Name of Drug #1: ORGOVYX

Open Associated Drug #1: 72974-120-01


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812732031

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: HEMATOLOGY

Name of Drug #1: ADAKVEO

Open Associated Drug #1: 0078-0883-61


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812732033

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: PROMACTA

Open Associated Drug #1: 0078-0686-15

Drug or Biological: Drug

Product Category #2: HEMATOLOGY

Name Of Drug #2:: TASIGNA

Associated Drug #2: 0078-0526-51


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812732035

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: HEMATOLOGY

Name of Drug #1: ADAKVEO

Open Associated Drug #1: 0078-0883-61


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812732037

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: PROMACTA

Open Associated Drug #1: 0078-0686-15

Drug or Biological: Drug

Product Category #2: HEMATOLOGY

Name Of Drug #2:: TASIGNA

Associated Drug #2: 0078-0526-51


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812732039

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: PROMACTA

Open Associated Drug #1: 0078-0686-15


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 841911635

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology/Endocrinology

Name of Drug #1: SOMATULINE DEPOT

Open Associated Drug #1: 15054-0060-1

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: ONIVYDE

Associated Drug #2: 15054-0043-1


Additional Office Locations

1. Saint Francis Hospital, Inc.
6161 S Yale Ave
Tulsa, OK 74136
Group Members: 39

Phone: 918-488-6000

Enter a starting address:


Hematology/oncology Professionals in Tulsa

12697 E 51st St
Tulsa, OK
Oklahoma Cancer Specialists And Research Institute, Llc

8801 S 101st E Ave
Tulsa, OK
Genesiscare Landmark Oklahoma Cancer Care Pc

6600 S Yale Ave
Tulsa, OK
Warren Clinic Inc

6161 S Yale Ave
Tulsa, OK
Saint Francis Hospital, Inc.

12697 E 51st St
Tulsa, OK
Oklahoma Cancer Specialists And Research Institute, Llc

12697 E 51st St
Tulsa, OK
Oklahoma Cancer Specialists And Research Institute, Llc

Providers in Warren Clinic Inc

1.Kamran Abbasi Md

6161 S Yale Ave
Tulsa Ok 74136-1902
Warren Clinic Inc
Hospitalist

2.Kent Abernathy

6161 S Yale Ave
Tulsa Ok 74136-1902
Warren Clinic Inc
Obstetrics/gynecology

3.Kent Abernathy

6600 S Yale Ave
Tulsa Ok 74136-3331
Warren Clinic Inc
Obstetrics/gynecology

4.Rebecca Abraham

6600 S Yale Ave
Tulsa Ok 74136-3331
Warren Clinic Inc
Family Practice

5.Christopher Abshere Md

6600 S Yale Ave
Tulsa Ok 74136-3331
Warren Clinic Inc
Family Practice

6.Muhammad Afzal

6161 S Yale Ave
Tulsa Ok 74136-1902
Warren Clinic Inc
Nephrology

View all 605 members of Warren Clinic Inc medical group